Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | SNCA | P37840 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2502156 | 1.00 | BLM (0.46) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL10548139 | 1.00 | BLM (0.46) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL15823715 | 1.00 | BLM (0.46) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL2502158 | 1.00 | BLM (0.46) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL20421415 | 0.98 | BLM (0.48) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL11762171 | 0.94 | LMNA (0.41) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL11762165 | 0.94 | LMNA (0.41) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL11757242 | 0.88 | ALDH1A1 (0.36) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL11757239 | 0.88 | ALDH1A1 (0.36) | BLMLMNAPTPN1CYP3A4ALDH1A1 | |
| SCHEMBL11764969 | 0.87 | ALDH1A1 (0.40) | BLMLMNAPTPN1CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2935176-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | claimed |
| EP-2935191-B1 | PREPARATION OF (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE FROM 3,7-DIMETYLOCT-2-ENAL OR 3,7-DIMETYLOCTA-2,6-DIENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | claimed |
| EP-2935176-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP Assets B.V. (NL) | 2015-10-28 | — | — | EP | claimed |
| EP-2935191-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 3,7-DIMETYLOCT-2-ENAL OR 3,7-DIMETYLOCTA-2,6-DIENAL | DSM IP Assets B.V. (NL) | 2015-10-28 | — | — | EP | claimed |
| WO-2014096063-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 3,7-DIMETYLOCT-2-ENAL OR 3,7-DIMETYLOCTA-2,6-DIENAL | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | WO | claimed |
| WO-2014096066-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | WO | claimed |
| EP-2935186-B1 | POLYTHIOLS AS CIS/TRANS ISOMERIZATION CATALYSTS FOR UNSATURATED COMPOUNDS | DSM IP ASSETS BV (NL) | 2020-03-25 | — | — | EP | disclosed |
| CN-110563566-A | Nitric oxide as a catalyst for cis/trans isomerization of unsaturated compounds | 帝斯曼知识产权资产管理有限公司 | 2019-12-13 | — | — | CN | disclosed |
| EP-2935176-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | disclosed |
| EP-2935191-B1 | PREPARATION OF (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE FROM 3,7-DIMETYLOCT-2-ENAL OR 3,7-DIMETYLOCTA-2,6-DIENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | disclosed |
| US-9765002-B2 | Polythiols as cis/trans isomerization catalysts for unsaturated compounds | DSM IP ASSETS B.V. (NL) | 2017-09-19 | — | — | US | disclosed |
| US-9434671-B2 | Nitrogen monoxide as cis/trans isomerization catalysts for unsaturated compounds | DSM IP ASSETS B.V. (NL) | 2016-09-06 | — | — | US | disclosed |
| US-20150321987-A1 | NITROGEN MONOXIDE AS CIS/TRANS ISOMERIZATION CATALYSTS FOR UNSATURATED COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2015-11-12 | — | — | US | disclosed |
| WO-2014096063-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 3,7-DIMETYLOCT-2-ENAL OR 3,7-DIMETYLOCTA-2,6-DIENAL | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014097172-A1 | NITROGEN MONOXIDE AS CIS/TRANS ISOMERIZATION CATALYSTS FOR UNSATURATED COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | WO | disclosed |
| US-4882441-A | VITAMIN E DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 1989-11-21 | — | — | US | disclosed |
| US-4879395-A | Vitamin E intermediate | HOFFMANN-LA ROCHE INC. (US) | 1989-11-07 | — | — | US | disclosed |
| US-4853472-A | Vitamin E intermediates | HOFFMANN-LA ROCHE INC. (US) | 1989-08-01 | — | — | US | disclosed |
| US-4789750-A | 2-(trimethyl-tridecenyl)-tetramethylchroman intermediates for vitamin E | HOFFMAN-LA ROCHE INC. (US) | 1988-12-06 | — | — | US | disclosed |
| EP-0283946-A1 | Novel intermediates useful in preparing vitamin E | F. HOFFMANN-LA ROCHE AG (CH) | 1988-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150321987-A1 | NITROGEN MONOXIDE AS CIS/TRANS ISOMERIZATION CATALYSTS FOR UNSATURATED COMPOUNDS | FASN, NOS2, NOS1 | BLM 3969/4885LMNA 1130/4885PTPN1 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.